Patents by Inventor Matthew Warman

Matthew Warman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MAP2K1 (MEK1) as a therapeutic target for arteriovenous malformations and associated disorders
    Patent number: 11104955
    Abstract: The instant disclosure provides methods and compositions related to discovery of MAP2K (MEK1) as a therapeutic target for treatment or prevention of arteriovenous malformations (AVMs). Therapeutic and/or prophylactic uses and compositions of known MEK1 inhibitors, including small molecules and nucleic acid agents, are described.
    Type: Grant
    Filed: December 29, 2017
    Date of Patent: August 31, 2021
    Assignee: CHILDREN'S MEDICAL CENTER CORPORATION
    Inventors: Arin K. Greene, Matthew Warman, Yue Huang
  • MAP2K1 (MEK1) AS A THERAPEUTIC TARGET FOR ARTERIOVENOUS MALFORMATIONS AND ASSOCIATED DISORDERS
    Publication number: 20200024666
    Abstract: Please insert the following Abstract on a separate sheet at the end of the application: The instant disclosure provides methods and compositions related to discovery of MAP2K (MEK1) as a therapeutic target for treatment or prevention of arteriovenous malformations (AVMs). Therapeutic and/or prophylactic uses and compositions of known MEK1 inhibitors, including small molecules and nucleic acid agents, are described.
    Type: Application
    Filed: December 29, 2017
    Publication date: January 23, 2020
    Inventors: Arin K. Greene, Matthew Warman, Yue Huang